Yes, research suggests that NAD and Glutathione may support brain health and potentially slow the progression of neurodegenerative diseases like Alzheimer's and Parkinson's by enhancing DNA repair and reducing oxidative damage
Wang W, Wang Q, Qi X, Gurney M, Perry G, Volkow ND, et al
& Mehendale, A
In June 2021, the FDA approved the once weekly semaglutide injection of dulaglutide (Trulicity) for treating obesity
Gastroparesis with the initiation of liraglutide: A case report
For cagrilintide specifically, the coming years will determine whether its distinct mechanism can carve out a meaningful roleeither as a standalone therapy through the RENEW program or as part of combination approaches like CagriSema and potentially future pairings Other questions about cagrilintide Because cagrilintide is still in clinical development, many common questions relate to its availability, safety, and how it compares with existing medications